Monitoring with mean kinetic temperature in GxP environments

Supplied by Vaisala Oyj on Tuesday, 14 February, 2017

Regulatory bodies in drug manufacturing and distribution have long been working together to create standards for temperature monitoring that will ensure the quality of drugs, devices and biotechnology. The mean kinetic temperature (MKT) value has been identified as a potential tool for evaluating the impact of temperature on product quality.

Download this paper to discover how to perform the calculation and some basic recommendations for its appropriate use.

DOWNLOAD

5 Pages PDF

Related White Papers

How to leverage the latest digital tech and cut your costs

Discover how to go paperless in your lab and...

3 critical factors of successfully deploying a single ELN in your lab

Download this use case to learn the 3 key factors...

Your guide to cell-based fluorescence assays

Learn how to master the challenges of cell-based fluorescence assays and improve the quality and...

Content from other channels on our network

New fund drives waste sector innovation

Epson on CDP 'A List'

APCO and SPSA partner on soft plastics stewardship

Partnership creates national manufacturing roadmap

$2.1bn battery recycling sector critical to Australia's sovereign capability

Unilever in discussions about its Foods business

From wheat waste to functional ingredient for future foods

True Protein builds its operational muscle using AI-powered system

Late‑Model Dairy Manufacturing and Packaging Equipment Offered by EOI in Victoria

Improving efficiency of pharma packaging cleaning after filling

Ahpra launches the National Scheme Strategy 2031

The Agency establishes National Clinical Governance Committee for Digital Health

'No evidence' of medicinal cannabis effectiveness treating anxiety, depression or PTSD

COVID-19 training fail lands residential aged care provider $150K fine

AdPha partners with Therapeutic Guidelines to deliver obesity clinical guidance